Sanofi Asks To Go Solo With Its EpiPen Fight Against Mylan
Sanofi-Aventis US LLC on Thursday implored the Judicial Panel on Multidistrict Litigation to keep its anti-competition suit against EpiPen maker Mylan Inc. separate from putative purchaser class actions over pricing, saying...To view the full article, register now.
Already a subscriber? Click here to view full article